X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (379) 379
Book Review (33) 33
Conference Proceeding (32) 32
Publication (15) 15
Book Chapter (2) 2
Dissertation (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (219) 219
humans (202) 202
pulmonary hypertension (144) 144
respiratory system (139) 139
male (121) 121
female (117) 117
middle aged (104) 104
cardiac & cardiovascular systems (87) 87
adult (76) 76
abridged index medicus (71) 71
aged (71) 71
hypertension (71) 71
hypertension, pulmonary - drug therapy (71) 71
hypertension, pulmonary - physiopathology (55) 55
diagnosis (54) 54
treatment outcome (53) 53
survival (48) 48
care and treatment (43) 43
hypertension, pulmonary - diagnosis (43) 43
arterial-hypertension (41) 41
critical care medicine (41) 41
chronic disease (38) 38
hypertension, pulmonary - etiology (36) 36
pulmonary arterial hypertension (36) 36
hypertension, pulmonary - therapy (33) 33
risk factors (33) 33
therapy (33) 33
hemodynamics (32) 32
pulmonary arteries (32) 32
prospective studies (31) 31
retrospective studies (28) 28
bosentan (27) 27
mortality (27) 27
research (27) 27
surgery (27) 27
antihypertensive agents - therapeutic use (26) 26
guidelines (25) 25
pulmonary/respiratory (25) 25
cardiology (24) 24
drug therapy (24) 24
transplantation (24) 24
heart (23) 23
hypertension, pulmonary - mortality (23) 23
endarterectomy (22) 22
lung (22) 22
analysis (21) 21
double-blind method (21) 21
endothelin receptor antagonists (21) 21
patients (21) 21
pulmonary (21) 21
cardiovascular (20) 20
clinical trials (20) 20
double-blind (19) 19
lung transplantation (19) 19
respiratory agents (19) 19
severity of illness index (19) 19
usage (19) 19
young adult (19) 19
adolescent (18) 18
brain natriuretic peptide (18) 18
chronic thromboembolic pulmonary hypertension (18) 18
heart failure (18) 18
management (18) 18
medicine & public health (18) 18
registry (18) 18
vasodilator agents - therapeutic use (18) 18
aged, 80 and over (17) 17
health aspects (17) 17
hypertension, pulmonary (17) 17
medicine, general & internal (17) 17
outcomes (17) 17
placebo-controlled trial (17) 17
prognosis (17) 17
time factors (17) 17
drug therapy, combination (16) 16
embolism (16) 16
inhaled iloprost (16) 16
pulmonary embolism - complications (16) 16
cardiology and cardiovascular medicine (15) 15
disease (15) 15
hypertension, pulmonary - epidemiology (15) 15
internal medicine (15) 15
medical colleges (15) 15
studies (15) 15
thromboembolism (15) 15
familial primary pulmonary hypertension (14) 14
riociguat (14) 14
sildenafil (14) 14
sulfonamides - therapeutic use (14) 14
hypertension, pulmonary - complications (13) 13
peripheral vascular disease (13) 13
prostacyclin (13) 13
risk assessment (13) 13
angioplasty (12) 12
combination therapy (12) 12
follow-up studies (12) 12
hypertension, pulmonary - surgery (12) 12
kaplan-meier estimate (12) 12
lung diseases (12) 12
pulmonary artery - physiopathology (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (353) 353
German (23) 23
Spanish (4) 4
Polish (2) 2
Turkish (2) 2
French (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 834 - 844
Patients with previously untreated pulmonary arterial hypertension who were randomly assigned to combination therapy with ambrisentan and tadalafil had a... 
INHALED ILOPROST | SURVIVAL | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | EPOPROSTENOL | COMBINATION THERAPY | HEART-FAILURE | DOUBLE-BLIND | BOSENTAN | Hypertension, Pulmonary - mortality | Double-Blind Method | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Hypertension, Pulmonary - physiopathology | Male | Hospitalization | Disease Progression | Tadalafil | Phenylpropionates - therapeutic use | Peptide Fragments - blood | Adult | Female | Phenylpropionates - adverse effects | Aged | Hypertension, Pulmonary - drug therapy | Drug Therapy, Combination | Carbolines - therapeutic use | Carbolines - adverse effects | Natriuretic Peptide, Brain - blood | Pyridazines - adverse effects | Pyridazines - therapeutic use | Symptomatology | Care and treatment | Usage | Analysis | Clinical trials | Dosage and administration | Pulmonary hypertension | Ambrisentan | Hypertension | Edema | Brain natriuretic peptide | Headache | Functional morphology | Pulmonary arteries | Lung diseases | Drug therapy | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus | Drug side effects | Assaigs clínics de medicaments | Efectes secundaris dels medicaments | Hipertensió pulmonar | Drug testing | Life Sciences | Human health and pathology | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
European Respiratory Journal, ISSN 0903-1936, 04/2018, Volume 51, Issue 4, pp. 1800440 - 1800440
How many patients who survive acute pulmonary embolism will eventually develop chronic thromboembolic pulmonary hypertension (CTEPH) and is the risk... 
DIAGNOSIS | RESPIRATORY SYSTEM | GUIDELINES | REGISTRY | Hypertension | Embolisms | Pulmonary arteries | Lung | Thromboembolism | Health risk assessment | Embolism | Pulmonary hypertension
Journal Article
Circulation, ISSN 0009-7322, 04/2016, Volume 133, Issue 18, pp. 1731 - 1733
Surgical pulmonary endarterectomy (PEA) is unanimously considered the preferred treatment for chronic thromboembolic pulmonary hypertension (CTEPH), even... 
hypertension, pulmonary | Editorials | endarterectomy | pulmonary embolism | Endarterectomy - trends | Postoperative Care - trends | Hypertension, Pulmonary - diagnosis | Endarterectomy - adverse effects | Humans | Hypertension, Pulmonary - surgery | Hemodynamics | Postoperative Care - methods | Index Medicus | Abridged Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 05/2016, Volume 133, Issue 18, p. 1731
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 4, pp. 319 - 329
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 02/2018, Volume 20, Issue 2, pp. 256 - 259
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 26, pp. 2522 - 2533
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A2650 - A2650
Journal Article
European Respiratory Journal, ISSN 0903-1936, 02/2017, Volume 49, Issue 2, pp. 1602522 - 1602522
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare form of pulmonary hypertension, classified as group 4 in the present clinical classification... 
EMBOLISM | RESPIRATORY SYSTEM | Hypertension, Pulmonary | Pulmonary Embolism | Rare Diseases | Humans | Incidence | Hypertension | Blood pressure | Thromboembolism | Health risk assessment | Embolism | Pulmonary hypertension | Index Medicus
Journal Article
European Respiratory Journal, ISSN 0903-1936, 08/2017, Volume 50, Issue 2, pp. 1602493 - 1602493
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, pp. e0141911 - e0141911
Journal Article